STATISTICAL PERSPECTIVES ON SUBGROUP ANALYSIS: TESTING FOR HETEROGENEITY AND EVALUATING ERROR RATE FOR THE COMPLEMENTARY SUBGROUP

被引:11
|
作者
Alosh, Mohamed [1 ]
Huque, Mohammad F. [2 ]
Koch, Gary G. [3 ]
机构
[1] US FDA, Div Biometr 3, Off Biostat, OTS,CDER, Silver Spring, MD 20993 USA
[2] US FDA, OTS, Off Biostat, CDER, Silver Spring, MD 20993 USA
[3] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA
关键词
Complementary subgroup error rate; Supportive assessment; Targeted subgroup; Testing for interaction; QUALITATIVE INTERACTIONS; CLINICAL-TRIALS; POWER;
D O I
10.1080/10543406.2014.971169
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Substantial heterogeneity in treatment effects across subgroups can cause significant findings in the overall population to be driven predominantly by those of a certain subgroup, thus raising concern on whether the treatment should be prescribed for the least benefitted subgroup. Because of its low power, a nonsignificant interaction test can lead to incorrectly prescribing treatment for the overall population. This article investigates the power of the interaction test and its implications. Also, it investigates the probability of prescribing the treatment to a nonbenefitted subgroup on the basis of a nonsignificant interaction test and other recently proposed criteria.
引用
收藏
页码:1161 / 1178
页数:18
相关论文
共 50 条
  • [21] An Explanation for the Recent Increase in the Fall Death Rate Among Older Americans: A Subgroup Analysis
    Hu, Guoqing
    Baker, Susan P.
    PUBLIC HEALTH REPORTS, 2012, 127 (03) : 275 - 281
  • [22] AN OVERVIEW OF STATISTICAL AND REGULATORY ISSUES IN THE PLANNING, ANALYSIS, AND INTERPRETATION OF SUBGROUP ANALYSES IN CONFIRMATORY CLINICAL TRIALS
    Hemmings, Robert
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2014, 24 (01) : 4 - 18
  • [23] Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis
    Hayward R.A.
    Kent D.M.
    Vijan S.
    Hofer T.P.
    BMC Medical Research Methodology, 6 (1)
  • [24] Appropriateness of statistical analysis for evaluating results of lipoprotein(a) testing
    Lippi, Giuseppe
    Guidi, Gian Cesare
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2008, 47 (09) : 973 - 973
  • [25] Regression-based heterogeneity analysis to identify overlapping subgroup structure in high-dimensional data
    Luo, Ziye
    Yao, Xinyue
    Sun, Yifan
    Fan, Xinyan
    BIOMETRICAL JOURNAL, 2022, 64 (06) : 1109 - 1141
  • [26] Estimating the subgroup and testing for treatment effect in a post-hoc analysis of aclinical trial with a biomarker
    Joshi, Neha
    Fine, Jason
    Chu, Rong
    Ivanova, Anastasia
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2019, 29 (04) : 685 - 695
  • [27] Testing moderator hypotheses in meta-analytic structural equation modeling using subgroup analysis
    Suzanne Jak
    Mike W.-L. Cheung
    Behavior Research Methods, 2018, 50 : 1359 - 1373
  • [28] Testing moderator hypotheses in meta-analytic structural equation modeling using subgroup analysis
    Jak, Suzanne
    Cheung, Mike W-L.
    BEHAVIOR RESEARCH METHODS, 2018, 50 (04) : 1359 - 1373
  • [29] Double space-time transmit diversity with subgroup rate control for UMTS:: Throughput analysis
    Mehlfuehrer, Christian
    Rupp, Markus
    Mecklenbraeuker, Christoph F.
    2005 39TH ASILOMAR CONFERENCE ON SIGNALS, SYSTEMS AND COMPUTERS, VOLS 1 AND 2, 2005, : 1258 - 1262
  • [30] Optimal statistical power for clinical subgroup analysis in COVID-19 genome wide association study
    Avramidis, Nikos
    Pirastu, Nicola
    Seth, Sohan
    Baillie, Kenneth
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 673 - 673